Navigation Links
Kinex Announces First Patient Dosed in Phase Ib Study of Oraxol, an Orally Dosed Paclitaxel
Date:10/28/2013

BUFFALO, N.Y., Oct. 28, 2013 /PRNewswire/ -- Kinex Pharmaceuticals today announced that the first patient has been dosed in its Phase Ib Oraxol study.  Oraxol allows for oral delivery of paclitaxel when combined with Hanmi Pharmaceutical's absorption enhancer, HM30181A.  This trial is being conducted in the United States.  Oraxol is in PII studies in Korea and will commence a PI in New Zealand in 2014.  Kinex has global development and commercialization rights for Oraxol, excluding Korea, Japan and India that are owned by Hanmi, and New Zealand and Australia which were recently licensed to Zenith Technology Corporation.

This single arm, dose escalation study is designed to bridge the safety, pharmacokinetics and tolerability of Oraxol that was observed by Hanmi Pharmaceutical in their Korean trials.  Kinex expects to enroll 25-35 patients.  Clinical studies of Oraxol to date suggest that this potent, oral version of paclitaxel will impact a broad spectrum of cancers.

Dr. Wen Wee Ma, MBBS, Assistant Professor at Roswell Park Cancer Institute and Primary Investigator for the Phase Ib trial stated, "Our team at Roswell Park has broad experience developing taxane based compounds.  Oraxol is an exciting program for us as it offers many important potential benefits to patients and clinicians including tolerability, convenience of oral administration and increased efficacy.  The design of this trial was guided by the predictive PK of Oraxol developed by Kinex and Roswell Park and we are extremely excited by its launch."

"The initiation of Kinex's Phase Ib is another important step in the Kinex /Hanmi collaboration," said Dr. Lyn Dyster, Senior Vice President of Operations. "The trial is des
'/>"/>

SOURCE Kinex Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Hanmi Pharmaceuticals to Assign the Rights to Five New Territories to Kinex as Part of the Orascovery Program Strategic Plan
2. Dr. David Hangauer, Chief Scientific Officer and Co-Founder, commits his career to Kinex Pharmaceuticals
3. Kinex Receives Research Support from the Hong Kong Innovation and Technology Commission (ITC)
4. Kinex Announces that the US FDA Allows their IND for Oraxol, an Oral Form of Paclitaxel that is in Phase II Clinical Trials in Korea, to Begin Clinical Trials in the US
5. Kinex Pharmaceuticals Will Take the Lead in the Orascovery Program Development in China
6. Kinex Announces that the US FDA Allows their IND to Begin KX02 Clinical Trials
7. Kinex Pharmaceuticals and Zenith Technology Corporation announce the execution of a collaborative licensing agreement
8. Kinex Pharmaceuticals Chief Scientific Officer, Dr. David Hangauer, named the American Cancer Societys 2013 Honoree for its Cuisine for a Cure event
9. Hanmi and Kinex Announced Korean FDA Allowance of the KX01 IND Application
10. Kinex Pharmaceuticals Appoints Mr. Patrick Gallagher Vice President of Business Development and Investor Relations
11. Kinex Pharmaceuticals Receives Substantial Strategic Investment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Young Innovations ("Young"), a leading global ... the acquisition of the professional dental contract manufacturing ... MPL PDCMD manufactures fluoride varnish, prophy paste and ... procedures. "This acquisition marks the ... high-growth segments," said Dave Sproat , CEO ...
(Date:8/4/2015)... -- Eli Lilly and Company (NYSE: LLY ) today ... its intent to end its contract with the university ... Alzheimer,s disease (A4) study. The A4 study is a ... of Alzheimer,s disease in older individuals who have evidence ... but do not show symptoms of memory impairment. A4 ...
(Date:8/4/2015)... 2015  IRIDEX Corporation (Nasdaq: IRIX ) today ... served as chief financial officer since 2008 and as ... with the Company, effective August 21, 2015, to accept ... Mackaness intends to continue to serve in the CFO/COO ... 10-Q filing. CEO William M. ...
Breaking Medicine Technology:Young Innovations Announces Acquisition of Medical Products Laboratories' Professional Dental Contract Manufacturing Division 2Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 2Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 3IRIDEX Chief Financial Officer Resigns to Accept Another Opportunity 2
... , , , , ... Amira Pharmaceuticals, Inc. announced today the submission of an Investigational New ... the treatment and control of inflammatory and allergic disease linked to ... , , AM461 is an oral, selective antagonist ...
... , JERUSALEM, August 18 ... of alternative drug,delivery systems, announced today that Oramed,s Chief ... overview of the clinical,development of Oramed,s Oral Insulin capsule ... Manchester, England on,September 9, 2009. , ...
Cached Medicine Technology:Amira Pharmaceuticals Submits IND for Second DP2 Antagonist, AM461 2Oramed's Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the 2009 British Pharmaceutical Conference in Manchester, England 2
(Date:8/4/2015)... , ... August 04, 2015 , ... Statement by Paul ... the introduction of the Mental Health Reform Act of 2015 by Senators ... mental health reform a reality in America. , “This legislation and H.R. ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... it has joined the American Association of Tissue Banks (AATB) as an Affiliate ... its mission “to honor donors, and to save and improve lives by promoting ...
(Date:8/4/2015)... ... August 04, 2015 , ... Rhode Island Medical Imaging (RIMI) is pleased ... Medical Building on Wake Robin Road in Lincoln, RI. This satellite office will ... the most extensive out-patient x-ray hours in the state, which includes evenings and weekends. ...
(Date:8/4/2015)... Los Angeles, California (PRWEB) , ... August 04, ... ... bearing drawer slides to Los Angeles commercial customers. Finding reliable hardware can ... create unfortunate liabilities. When putting an office together or designing a new ...
(Date:8/4/2015)... Mountain View, CA (PRWEB) , ... August 04, ... ... 17th Surgeon General of the United States, Richard Carmona, M.D., M.P.H., FACS, to ... prevents catastrophic medication errors and will save lives," Dr. Carmona said. "I strongly ...
Breaking Medicine News(10 mins):Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 3Health News:Exsurco Medical Joins AATB as Affiliate Member 2Health News:Rhode Island Medical Imaging Opens Satellite Imaging Center on Wake Robin Road in Lincoln 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 3Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 4Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 2Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 3
... brain injury (TBI) affects many Americans: high school athletes, ... of domestic violence, to name a few. Some of ... in our soldiers and veterans returning from Iraq and ... with the Department of Defense to investigate the long-term ...
... Loyola University Chicago Stritch School of Medicine study could ... heart disease and cancer as well as more effective ... author Christopher Wiethoff, PhD, and colleagues report their findings ... Virology . Editors spotlighted the report as one of ...
... that the number of people diagnosed with autism has ... a surge in the number of adults with autism ... that this population may earn less and be employed ... disabilities. Now, an autism expert at the University of ...
... (HealthDay News) -- Studies on the effectiveness of cognitive rehabilitation ... a new report issued by the U.S. Institute of Medicine ... kind of therapy helps such patients regain lost mental and ... for its use. With traumatic brain injury (TBI) now ...
... HealthDay Reporter , TUESDAY, Oct. 11 (HealthDay News) ... pregnancy, may be due to a microscopic battle going on ... and those directed by the mother, a new study suggests. ... the activity of cells in the placenta, the new report ...
... Penn State University chemist has demonstrated the strengths and ... -- a technique used to analyze the surface of ... substances. In the new study, the researchers used computer ... of the alternative method, which is being used by ...
Cached Medicine News:Health News:Looking for a link between seizures and migraine after traumatic brain injury in soldiers 2Health News:Study could help improve gene therapy for heart disease, cancer 2Health News:Researcher identifies autism employment resources, tips for people with autism spectrum disorders 2Health News:Evidence Lacking That Cognitive Rehab Therapy Helps Brain-Injured Vets 2Health News:Evidence Lacking That Cognitive Rehab Therapy Helps Brain-Injured Vets 3Health News:Study Suggests Origins of Pregnancy-Linked High Blood Pressure 2Health News:Study Suggests Origins of Pregnancy-Linked High Blood Pressure 3Health News:Molecular depth profiling modeled using buckyballs and low-energy argon 2Health News:Molecular depth profiling modeled using buckyballs and low-energy argon 3
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medicine Products: